Dystrophin Antibody - BSA Free

Dystrophin is a muscle membrane protein (427 kDa) which is absent, reduced or altered as a result of mutation in Duchenne and Becker muscular dystrophies (DMD/BMD) or its homologue in the mouse.8 Severe DMD is associated with a marked dystrophin deficiency whereas patients with the milder form of BMD show less pronounced abnormalities of protein expression. Because abnormalities in the protein expression occur specifically in patients with these types of muscular dystrophy, dystrophin analysis may be used to distinguish these conditions from other neuromuscular diseases. Predictions from the sequence suggest a structural protein on the inner face of the membrane, consisting of a 25-repeat, rod-like triple-helical domain separating an N-terminal actin-binding domain from two C-terminal domains, one of which is rich in cysteine.9 The large size of dystrophin and its low abundance (<0.01% of the total muscle protein) are a hindrance to the isolation of intact, native protein for structure/function studies. Monoclonal antibodies against defined regions10 of dystrophin provide a means for studying its structure and function, interactions with other proteins and the nature of the partial gene products produced in some patients carrying deletions in the dystrophin gene. The antibodies are useful in the prenatal or post-abortion diagnosis of muscular dystrophy carriers by immunohistological analyses.11

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Mouse.

We have publications tested in 2 applications: ICC/IF, IF/IHC.

Showing Publications 1 - 4 of 4.

Publications using NBP1-89953	Applications	Species
Mondello C, Ventura Spagnolo E, Bartoloni G Et Al. Dystrophin and metalloproteinase 9 in myocardial ischemia: A post-mortem immunohistochemical study Legal medicine (Tokyo, Japan) 2021-07-25 [PMID: 34332258] (IF/IHC)	IF/IHC
Mondello C, Cardia L, Bartoloni G et al. Immunohistochemical study on dystrophin expression in CAD-related sudden cardiac death: a marker of early myocardial ischaemia Int. J. Legal Med. 2018-05-07 [PMID: 29732464] (IF/IHC)	IF/IHC
Kawase H, Bando YK, Nishimura K et al. A dipeptidyl peptidase-4 inhibitor ameliorates hypertensive cardiac remodeling via angiotensin-II/sodium-proton pump exchanger-1 axis J. Mol. Cell. Cardiol. 2016-06-30 [PMID: 27374118] (ICC/IF)	ICC/IF
Aoyama M, Kawase H, Bando YK et al. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis. Circ Heart Fail. 2016-01-01 [PMID: 26721911] (IF/IHC, Mouse)	IF/IHC	Mouse

Array NBP1-89953

• Dystrophin Antibodies
• Dystrophin ELISA Kits
• Dystrophin Lysates
• Dystrophin Proteins